PVLA: PALVELLA THERAPEUTICS, INC. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 17 sales totaling $3.58M in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-10-14Jenkins George MDirector$58Kyes
2026-10-14Jenkins George MDirector$254Kyes
2026-10-14Jenkins George MDirector$321Kyes
2026-10-14Jenkins George MDirector$114Kyes
2026-10-14Jenkins George MDirector$75Kyes
2026-10-14Jenkins George MDirector$64Kyes
2026-10-13Jenkins George MDirector$258Kyes
2026-10-13Jenkins George MDirector$212Kyes
2026-10-13Jenkins George MDirector$129Kyes
2026-10-13Jenkins George MDirector$136Kyes
2026-10-13Jenkins George MDirector$77Kyes
2026-10-13Jenkins George MDirector$123Kyes
2026-10-12Jenkins George MDirector$676Kyes
2026-10-12Jenkins George MDirector$328Kyes
2026-10-12Jenkins George MDirector$448Kyes
2026-10-12Jenkins George MDirector$196Kyes
2026-10-12Jenkins George MDirector$111Kyes

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-1413G amendmentFirst Light Asset Management, LLC5.34%SEC
2026-08-14Fell below 5%BIOTECHNOLOGY VALUE FUND L P4.70%SEC
2026-08-10New 13G stakePRUDENTIAL FINANCIAL INC6.70%SEC
2026-08-03New 13G stakeJennison Associates LLC6.70%SEC

Get new insider and activist filings the morning after: daily alerts. Not investment advice.